These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33347938)

  • 1. Universal risk assessment upon hospital admission for screening of carriage with multidrug-resistant micro-organisms in a Dutch tertiary care centre.
    van Hout D; Bruijning-Verhagen PCJ; Blok HEM; Troelstra A; Bonten MJM
    J Hosp Infect; 2021 Mar; 109():32-39. PubMed ID: 33347938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk factors associated with multi-drug resistant organisms (MDRO) carriage among pediatric patients at the time of admission in a tertiary care hospital of a developing country. A cross-sectional study.
    Qureshi S; Maria N; Zeeshan M; Irfan S; Qamar FN
    BMC Infect Dis; 2021 Jun; 21(1):547. PubMed ID: 34107903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proportion of asylum seekers carrying multi-drug resistant microorganisms is persistently increased after arrival in the Netherlands.
    Ravensbergen SJ; Louka C; Ott A; Rossen JW; Cornish D; Pournaras S; Bathoorn E; Stienstra Y
    Antimicrob Resist Infect Control; 2019; 8():6. PubMed ID: 30637100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited multi-drug resistant organism related stigma in carriers exposed to isolation precautions: an exploratory quantitative questionnaire study.
    Wijnakker R; Lambregts MMC; Rump B; Veldkamp KE; Reis R; Visser LG; de Boer MGJ
    J Hosp Infect; 2020 Sep; 106(1):126-133. PubMed ID: 32628981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal versus targeted additional contact precautions for multidrug-resistant organism carriage for patients admitted to an intensive care unit.
    Djibré M; Fedun S; Le Guen P; Vimont S; Hafiani M; Fulgencio JP; Parrot A; Denis M; Fartoukh M
    Am J Infect Control; 2017 Jul; 45(7):728-734. PubMed ID: 28285725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with bacteraemia due to multidrug-resistant organisms among bacteraemic patients with multidrug-resistant organism carriage: a case control study.
    Mascitti H; Duran C; Nemo EM; Bouchand F; Câlin R; Descatha A; Gaillard JL; Lawrence C; Davido B; Barbier F; Dinh A
    Antimicrob Resist Infect Control; 2018; 7():116. PubMed ID: 30288256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Risk Factors for Multidrug-Resistant Organisms in Community-Acquired Bacterial Pneumonia at a Community Hospital.
    Covington EW; Rufe A
    J Pharm Pract; 2023 Apr; 36(2):303-308. PubMed ID: 34406082
    [No Abstract]   [Full Text] [Related]  

  • 8. Airway multidrug-resistant organisms in a population of tracheostomy and chronic ventilator-dependent children at a tertiary care pediatric hospital.
    Havens TN; Rosen DA; Rivera-Spoljaric K
    Pediatr Pulmonol; 2023 Jan; 58(1):26-34. PubMed ID: 36100968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence and risk factors of multi-drug resistant organism colonization among long-term care facilities in Gran Canaria (Spain)].
    Del Rosario-Quintana C; Tosco-Núñez T; Lorenzo L; Martín-Sánchez AM; Molina-Cabrillana J
    Rev Esp Geriatr Gerontol; 2015; 50(5):232-6. PubMed ID: 25576447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying patients at high risk for multidrug-resistant organisms after hospitalization abroad.
    Bopp TC; Marchesi M; Zihlmann R; Sax H; Wolfensberger A
    Infect Control Hosp Epidemiol; 2023 Aug; 44(8):1281-1288. PubMed ID: 36912341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Readmissions With Multidrug-Resistant Infection in Patients With Prior Multidrug Resistant Infection.
    Burnham JP; Kwon JH; Olsen MA; Babcock HM; Kollef MH
    Infect Control Hosp Epidemiol; 2018 Jan; 39(1):12-19. PubMed ID: 29248023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collateral benefit of screening patients for methicillin-resistant Staphylococcus aureus at hospital admission: isolation of patients with multidrug-resistant gram-negative bacteria.
    Jones M; Nielson C; Gupta K; Khader K; Evans M
    Am J Infect Control; 2015 Jan; 43(1):31-4. PubMed ID: 25442394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compliance to Screening Protocols for Multidrug-Resistant Microorganisms at the Emergency Departments of Two Academic Hospitals in the Dutch-German Cross-Border Region.
    Gunnink LB; Arouri DJ; Jolink FEJ; Lokate M; de Jonge K; Kampmeier S; Kreis C; Raschke M; Kleinjan M; Ter Maaten JC; Friedrich AW; Bathoorn E; Glasner C
    Trop Med Infect Dis; 2021 Jan; 6(1):. PubMed ID: 33530494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of MRSA and ESBL among asylum seekers in the Netherlands.
    Ravensbergen SJ; Berends M; Stienstra Y; Ott A
    PLoS One; 2017; 12(4):e0176481. PubMed ID: 28441421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective multicentre screening study on multidrug-resistant organisms in intensive care units in the Dutch-German cross-border region, 2017 to 2018: the importance of healthcare structures.
    Glasner C; Berends MS; Becker K; Esser J; Gieffers J; Jurke A; Kampinga G; Kampmeier S; Klont R; Köck R; von Müller L; Al Naemi N; Ott A; Ruijs G; Saris K; Tami A; Voss A; Waar K; van Zeijl J; Friedrich AW
    Euro Surveill; 2022 Feb; 27(5):. PubMed ID: 35115078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First multicenter study on multidrug resistant bacteria carriage in Chinese ICUs.
    Ma X; Wu Y; Li L; Xu Q; Hu B; Ni Y; Wu A; Sun S; Jarlier V; Robert J
    BMC Infect Dis; 2015 Aug; 15():358. PubMed ID: 26290050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active surveillance at the time of hospital admission for multidrug-resistant microorganisms among patients who had recently been hospitalized at health care facilities.
    Yoon YK; Ryu JM; Lee MJ; Lee SE; Yang KS; Lee CK; Kim MJ; Sohn JW
    Am J Infect Control; 2019 Oct; 47(10):1188-1193. PubMed ID: 31122673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SHIELD Orange County Project: Multidrug-resistant Organism Prevalence in 21 Nursing Homes and Long-term Acute Care Facilities in Southern California.
    McKinnell JA; Singh RD; Miller LG; Kleinman K; Gussin G; He J; Saavedra R; Dutciuc TD; Estevez M; Chang J; Heim L; Yamaguchi S; Custodio H; Gohil SK; Park S; Tam S; Robinson PA; Tjoa T; Nguyen J; Evans KD; Bittencourt CE; Lee BY; Mueller LE; Bartsch SM; Jernigan JA; Slayton RB; Stone ND; Zahn M; Mor V; McConeghy K; Baier RR; Janssen L; O'Donnell K; Weinstein RA; Hayden MK; Coady MH; Bhattarai M; Peterson EM; Huang SS
    Clin Infect Dis; 2019 Oct; 69(9):1566-1573. PubMed ID: 30753383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point-of-care universal screening for meticillin-resistant Staphylococcus aureus: a cluster-randomized cross-over trial.
    Wu PJ; Jeyaratnam D; Tosas O; Cooper BS; French GL
    J Hosp Infect; 2017 Mar; 95(3):245-252. PubMed ID: 27658666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs of outpatient and inpatient MRSA screening and treatment strategies for patients at elective hospital admission - a decision tree analysis.
    Hutzschenreuter L; Flessa S; Dittmann K; Hübner NO
    Antimicrob Resist Infect Control; 2018; 7():147. PubMed ID: 30519461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.